Clinical Trial Detail

NCT ID NCT04244552
Title First-in-Human Dose Escalation Trial of ATRC-101 in Adults With Advanced Solid Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Atreca, Inc.
Indications

lung non-small cell carcinoma

breast cancer

acral lentiginous melanoma

colorectal cancer

ovarian cancer

Therapies

ATRC-101

Age Groups: adult senior

No variant requirements are available.